文献速递胰腺与胆道疾病

干血斑免疫反应性胰蛋白酶原作为儿童胰腺疾病外分泌功能生物标志物的验证

Validation of Dried Blood Spot Immunoreactive Trypsinogen as a Biomarker of Exocrine Pancreas Function in Children With Pancreas Disease.
PubMed 文献 · Am J Gastroenterol · 2025-10-15

该研究验证干血斑免疫反应性胰蛋白酶原(DBS-IRT)作为儿童胰腺外分泌功能生物标志物的分析准确性和临床有效性。在28名儿童中评估分析准确性,在134名代谢稳定儿童中建立参考范围,并在164名胰腺表型明确的儿童中进行临床验证。DBS-IRT与放射免疫分析法(RIA)血清胰蛋白酶相关性好(r=0.95,P<0.001),鉴别囊性纤维化组胰腺外分泌功能不全(EPI)的灵敏度为90.7%(95%CI:79.7%-96.9%),特异度为94.7%(95%CI:73.9%-99.8%)。

要点

  • DBS-IRT与RIA血清胰蛋白酶高度相关(r=0.95,P<0.001),可替代其用于临床。
  • 新建立DBS-IRT参考范围为6.9-21.2 ng/mL。
  • DBS-IRT鉴别囊性纤维化患儿EPI灵敏度90.7%、特异度94.7%。

核心结论

  • DBS-IRT成功验证为胰腺外分泌功能生物标志物,可在临床中与粪便弹性蛋白酶一起用于评估胰腺功能。

研究设计与样本

  • 分析准确性在28名已知胰腺功能状态的儿童中评估,并与RIA血清胰蛋白酶同时检测。
  • 参考范围基于134名代谢稳定儿童建立。
  • 临床验证在164名胰腺表型明确的儿童中进行,并回顾影像学评估胰腺萎缩。

主要发现

  • DBS-IRT总不精密度范围为7.1%至16.4%,样本在-20℃下稳定28天。
  • DBS-IRT与RIA血清胰蛋白酶相关性极好(r=0.95,P<0.001)。
  • DBS-IRT鉴别囊性纤维化组EPI的灵敏度为90.7%(95%CI:79.7%-96.9%),特异度为94.7%(95%CI:73.9%-99.8%)。
  • 胰腺炎合并EPI的儿童DBS-IRT中位数显著低于无EPI者(P=0.01)。
  • 低DBS-IRT与胰腺萎缩相关(P=0.001)。

关键数值与推荐

  • DBS-IRT参考范围:6.9-21.2 ng/mL。

临床怎么用

  • DBS-IRT可作为儿童胰腺外分泌功能的临床生物标志物,尤其适用于囊性纤维化新生儿筛查项目普及的地区。
  • DBS-IRT可与粪便弹性蛋白酶联合用于评估胰腺功能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Radioimmunoassay (RIA)-serum trypsin serves as a pancreas function biomarker because its blood concentration correlates with duodenal trypsin output. With the unavailability of RIA tests and global availability of dried blood spot immunoreactive trypsin (DBS-IRT) testing as part of cystic fibrosis newborn-screening programs, IRT can be made accessible for routine clinical use. We aimed to validate DBS-IRT for its use as a biomarker of exocrine pancreas function in children older than the newborn age group. METHODS: Analytical accuracy of DBS-IRT was evaluated in 28 children (mean [SD] age: 13 [4.5] years) with known pancreas function status and simultaneous RIA-based serum trypsin testing. Reference ranges were established based on 134 metabolically stable children. Clinical validation was performed in 164 children with well-established pancreas phenotypes. Available cross-sectional imaging was reviewed to assess for pancreas atrophy to measure acinar cell loss. RESULTS: Total imprecision of DBS-IRT ranged from 7.1% to 16.4%; samples were stable samples at -20C for 28 days and showed excellent correlation to RIA-serum trypsin (r = 0.95, P < 0.001). A reference range of 6.9-21.2 ng/mL was newly established. DBS-IRT replicated serum trypsin in discriminating exocrine pancreatic insufficiency (EPI) in the cystic fibrosis group with high sensitivity (90.7%; 95% CI: 79.7%-96.9%) and specificity (94.7%; 95% CI: 73.9%-99.8%). Children with pancreatitis and EPI had significantly lower median DBS-IRT level compared with those without EPI ( P = 0.01). Low DBS-IRT was associated with pancreas atrophy ( P = 0.001). DISCUSSION: DBS-IRT was successfully validated as a biomarker of exocrine pancreas function which allows its use in clinical setting, in addition to fecal elastase to determine pancreas function.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Gummadi VV, Ren A, Zhang L, et al. Validation of Dried Blood Spot Immunoreactive Trypsinogen as a Biomarker of Exocrine Pancreas Function in Children With Pancreas Disease. Am J Gastroenterol. 2025. PMID: 41090999. doi:10.14309/ajg.0000000000003792

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。